Site Search

ATLANTA, Ga. – January 5, 2024 – Statement from Julie Vojtech , American Cancer Society Cancer Action Network (ACS CAN) Georgia government relations director: “As Georgia lawmakers dive into the 2024 legislative session, ACS CAN urges them to prioritize legislation to ease the burden of cancer on Georgians. Georgia is one of only 10 states that has not closed the coverage gap by fully expanding Medicaid, which would extend ... and caregivers from qualifying. Pathways also costs the state more money to cover fewer people than full Medicaid expansion; the estimated cost to the state for each new Pathways enrollee is $2,490, whereas full Medicaid expansion would cost the state $496 per new enrollee. “Some of ...

... Legislative Priorities Victory in the fight against cancer requires bold new public policies that promote cancer prevention, early detection of cancer, and expand access to quality, affordable health care. Lawmakers make many decisions that impact the lives of New York State residents ... impacted by cancer and their leadership is vital to defeating this disease. In 2023, the American Cancer Society Cancer Action Network (ACS CAN) will work with the Massachusetts State Legislature on legislative efforts that provide affordable, adequate access to health insurance ... cessation benefit that covers individual, group, and telephone counseling and all FDA-approved tobacco cessation medications without cost-sharing or other barriers to accessing care.  Cancer Prevention and Early Detection Reduce Incidence and Death from Pancreatic Cancer: ACS ...

... DC -- November 16, 2015 -- The Food & Drug Administration (FDA) released a report this afternoon looking at the evidence supporting oversight of lab-developed tests. See the link below to the report and an FDA blog post. Beneath those is a statement from the American Cancer Society Cancer Action Network (ACS CAN): http://blogs.fda.gov/fdavoice/ index.php/2015/11/why-fda- should-oversee-laboratory- developed-tests/ Statement from ACS CAN: The FDA report provides examples of how a lack of oversight of laboratory developed tests can result in misdiagnoses that can have life-threatening consequences. False results, or ...

WASHINGTON, D.C. – March 4, 2024 – Today, the U.S. Court of Appeals for the Fifth Circuit will hear oral arguments in Braidwood Management v. Becerra, a case that threatens access to evidence-based preventive services without cost-sharing as required under the Affordable Care Act (ACA). The services at-risk include those recommended by scientific experts at the U.S. ... health groups (listed below) filed an amicus brief citing research showing how cost-sharing decreases patients’ ability to receive care that can prevent disease, identify illness early and reduce the physical and financial burden of severe illnesses.   The below statement can be ...